Background: Mucous membrane pemphigoid (MMP) is a heterogeneous group of blistering disorders affecting the mucosae with or without skin involvement, characterized by the presence of autoantibodies to components of the basement membrane zone, including the bullous pemphigoid antigen BP180 and β4 integrin. Current literature has shown that a minority of patients present circulating antibodies to laminin-332 and this population seems to be associated with a relatively high risk of malignancy.
autoantibodies, as well as anti-purified human laminin-332.
The investigation described was carried out on residual biopsy sections following diagnostic analysis during the course of institutional diagnostic services, and the study was exempted from institutional review board review.
Discussion
MMP is an autoimmune bullous disorder with predominant or exclusive mucosal involvement. As reported for para- an associated neoplasia was found in 18 (11.7%) of them [13] . In this French study, the prevalence and significance of anti-laminin-332 was analyzed, showing that the presence of these antibodies is directly correlated with the severity of the disease, but not exclusively with the presence of a neoplasm.
In fact, of these 18 patients, they showed that only 2 (6.4%)
were laminin-332 positive, while 16 (13%) were laminin-332 of MMP preceded the tumor diagnosis or was synchronous (11 and 5 cases, respectively), whereas in 9 patients the bullous disorder occurred after the cancer detection (metachronous) ( Table 2) .
Determining a true paraneoplastic syndrome is often impossible. In fact, most neoplasms are initially occult and asymptomatic. In particular, a true paraneoplastic syndrome comprises the contemporaneous presence (or detection) of both dermatosis and cancer, with resolution of symptoms after cancer healing, and possible recurrence after cancer relapse. Therefore, the term "paraneoplastic" is used only for a subtype of pemphigus, while the term "associated malignancies" must be preferred in the other autoimmune blistering disorders, including MMP [37] .
In our case series, 3 patients developed the malignancy 1 to 3 years after the MMP diagnosis. A woman had breast cancer 1 year before MMP occurrence. Although 1 of our patients died from metastases 1.5 year after MMP diagnosis (case 2), the others cleared their bullous disease after cancer removal and are still under follow-up (range, 2-5 years) in our clinic without recurrences.
Conclusions
The clinical importance of determining specific antibodies in autoimmune blistering disorders is well known. For example, the presence of BP180 and/or BP230 in bullous pemphigoid may represent an active disease also in the absence of clinical symptoms [38] . In this regard, various studies demonstrate the correlation between laminin-332 MMP and cancer, underscoring the importance of immunological diagnosis of these autoantibodies [7, 10] .
On the other hand, and in accordance with the recent study by Bernard and coworkers [13] , our data demonstrate the relatively frequent association of MMP with a solid cancer, but no significant correlation with autoantibody detection. However, it is possible that laminin-332 reactivity is correlated with the severity of the disease, but needs to be determined by further studies.
